President Trump will announce today an agreement with Pfizer (PFE) to voluntarily sell the company’s medications through Medicaid at lower prices, Dan Diamond of Washington Post reports, citing two people who poke on the condition of anonymity. The Trump administration is seeking to lower drug prices in the U.S. to the lowest cost of drugs paid by the wealthiest countries, the Post notes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s Strategic Acquisitions and Undervalued Position Drive Buy Rating
- Metsera downgraded to Equal Weight from Overweight at Wells Fargo
- Mixed options sentiment in Pfizer with shareslittle changed
- GlaxoSmithKline Stock (GSK) Up as CEO Emma Walmsley Steps Down for Luke Miels
- Trump Weekly: President threatens new tariffs, announces TikTok deal